About Polpharma
Polpharma is a Healthcare company based in Starogard Gdanski (Poland) founded in 1935. Pharmaceuticals and active ingredients are manufactured and researched. Polpharma has completed 1 acquisition, including Polfa Warszawa. Its website polpharma.pl draws about 28 thousand monthly visits. Polpharma offers products and services including Generic Drugs, Supplements, and Acard. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA.
Company details
The company was founded in 1935 in Starogard Gdanski, Poland, within the pharmaceutical sector. A range of medications, including over-the-counter and prescription varieties, is produced alongside active pharmaceutical ingredients. Operations encompass research and development aimed at innovative therapies. Revenue is partially reinvested into new product development and enhancements to production and laboratory facilities. Scientific progress is aided through partnerships and funding efforts across Europe.
- Headquarters Starogard Gdanski, Poland
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website polpharma.pl
- Social LinkedIn Instagram
- Legal Name Zakłady Farmaceutyczne "Polpharma" Spółka Akcyjna
- Annual Revenue$809.28 K (USD)17as on Dec 31, 2022
- Net Profit$189.78 K (USD)12as on Dec 31, 2022
- EBITDA$170.08 K (USD)-8as on Dec 31, 2022
- Latest Funding Round$50.31M (USD), Debt – Venture
Jun 2015
- Investors
- Investments & Acquisitions
Products & Services of Polpharma
Polpharma offers a comprehensive portfolio of products and services, including Generic Drugs, Supplements, and Acard.
Manufactures treatments for respiratory and other conditions
Provides dietary and over-the-counter health aids
Offers pain relief and cardiovascular support options
Funding Insights of Polpharma
- Total Rounds 1
- Last Round Debt – Venture — $50.31M
- First Round $50.31M
(Jun 2015)
- Investors Count 1
All 1 funding rounds of Polpharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $50.31M | Debt – Venture | – | – |
1 investors in total: 1 institutional.
Investors in Polpharma
Polpharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include European Investment Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg |
Investor details for Polpharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Polpharma
87 people are tracked at Polpharma (34 in leadership, 53 in team).
| Name | Role | Group |
|---|---|---|
Gertjan N. | CFO Polpharma Group | Leadership |
Dorota Piskorska | Chief Corporate Development Officer | Leadership |
Robert Pławiak | CDIO / CTO | Leadership |
Artur Makarewicz | Business Finance Director Polpharma Group | Leadership |
Andrzej Tołoczko | Head Of Corporate Platforms Team | Leadership |
Ewelina Bogdal | Head Of HR Systems Team | Leadership |
Andrzej Z. | Head Of Sales&marketing Effectiveness | Leadership |
Szymon Przerada | Head Of Formulation Development Team | Leadership |
Tomasz Kosko | International Head Of Consumer Research And Communication | Leadership |
Piotr Hrycaj | Head Of Mergers And Acquisitions | Leadership |
Magda Brzezicka | Head Of IT Governance And IT Architecture | Leadership |
Mateusz Szeszko | Head Of IT Team For Commercial, Legal And ESG Applications | Leadership |
Dumitru Samohvalov | Acting Head Of Solid State Chemistry Team | Leadership |
Mariusz Adamski | Head Of Advanced Analytics Team | Leadership |
Julia Hrakovsky | Director Of R&d Department | Leadership |
Tomasz Bryja | Head Of API & B2b Controlling | Leadership |
Pawel Olszowy | Head Of Analytical Development Section | Leadership |
Dmitrij Wasilonek | Head Of The API And Procurement Applications IT Team | Leadership |
Michal Radowski | Head Of Technical Competence Center And B2b Portfolio, Polpharma B2b | Leadership |
Andrzej Wodecki | Marketing Director | Leadership |
67 more people are available in the full profile.
Complete people profiles for Polpharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polpharma
Polpharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Polfa Warszawa.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products are developed and quality-assessed at Polfa Warszawa. | polfawarszawa.pl | Warsaw, Poland | 1824 | Apr 2012 | •••• |
Complete acquisition details for Polpharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Polpharma
3 dated milestones of Polpharma across 80 years, from founding to its latest funding, stage changes and deals.
- Founded Polpharma is founded.
- Acquisition Acquires Polfa Warszawa.
- Funding First funding round of $50.3M.
Web traffic of Polpharma
The website of Polpharma (polpharma.pl) receives about 28.1K visits a month and ranks #1,405,803 among all websites worldwide, #1,820 in Biotechnology and Pharmaceuticals.
- Monthly visits28.1K
▲ 40.3% vs previous month
- Unique visitors9.8K
per month
- Global rank#1,405,803
among all websites
- Category rank#1,820
Health · Biotechnology and Pharmaceuticals
- Bounce rate56%
- Pages per visit1.7
- Average visit48 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Polpharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
gsk.com.pl | gsk.com.pl | 100% | – | ||
krkapolska.pl | krkapolska.pl | 99% | – | ||
servier.pl | servier.pl | 91% | #9,989,946 | – | |
teva.pl | teva.pl | 83% | #1,416,844 | – | |
ziololek.pl | ziololek.pl | 82% | #3,229,789 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Polpharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Polpharma
Complete news archive for Polpharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polpharma
Polpharma was founded in 1935 and raised its 1st funding round 80 years after it was founded.
Polpharma is headquartered in Starogard Gdanski, Poland. It is registered at Starogard Gdanski, Pomeranian Voivodeship, Poland.
Annual revenue of Polpharma is $809.28K as on Dec 31, 2022.
The company was founded in 1935 in Starogard Gdanski, Poland, within the pharmaceutical sector. A range of medications, including over-the-counter and prescription varieties, is produced alongside active pharmaceutical ingredients. Operations encompass research and development aimed at innovative therapies. Revenue is partially reinvested into new product development and enhancements to production and laboratory facilities. Scientific progress is aided through partnerships and funding efforts across Europe.
Polpharma offers Generic Drugs, Supplements, and Acard.
Polpharma has made 1 acquisition, including Polfa Warszawa.
Polpharma has 1 investor. Key investors include European Investment Bank.
Polpharma operates through Zakłady Farmaceutyczne "Polpharma" Spółka Akcyjna.